Universität Innsbruck
metadata only
CC BY 4.0
Pharmacology of a k-opioid receptor ligand with a new chemotype
Modulating the GPCR k-opioid receptor is a promising strategy for treating various human diseases, where receptor activation shows potential for treating pain without causing respiratory depression or risk of overdose of conventional µ-opioid analgesics, and receptor antag
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence.#848594
- Dex as Analgesic Adjuvant in OSA Patients#865045
- A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690,555 in Healthy Volunteers#1032008
- Anticancer platinum (IV) prodrugs with novel modes of activity#685923
- Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)#914100
Record · ID 1025312
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive